Lykos Therapeutics

Lykos Therapeutics is committed to making an impact on people’s lives. They envision a world where there are more tools available for the treatment of mental health and where conversations about mental health are destigmatized. There is an urgent need for more innovation. People need new options. Their mission is to transform mental healthcare. They are applying their decades of evidence-based research to develop investigational psychedelics to catalyze therapeutic approaches for mental health conditions. They are relentlessly exploring and reimagining novel approaches to address unmet needs in the mental healthcare space, with an initial focus on post-traumatic stress disorder (PTSD). As a public benefit corporation, they are focused on delivering positive impact on people, communities and society.